
PD-166866
CAS No. 192705-79-6
PD-166866( PD166866 | PD166866 | PD 166866 )
Catalog No. M17405 CAS No. 192705-79-6
PD166866 is a selective FGFR tyrosine kinase inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 31 | In Stock |
![]() ![]() |
5MG | 50 | In Stock |
![]() ![]() |
10MG | 78 | In Stock |
![]() ![]() |
25MG | 146 | In Stock |
![]() ![]() |
50MG | 289 | In Stock |
![]() ![]() |
100MG | 429 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NamePD-166866
-
NoteResearch use only, not for human use.
-
Brief DescriptionPD166866 is a selective FGFR tyrosine kinase inhibitor.
-
DescriptionPD166866 is a selective inhibitor of the FGF-1 receptor tyrosine kinase (FGFR1) with IC50 = 55 nM, and no effect on c-Src, PDGFR-b, EGFR or insulin receptor tyrosine kinases or MEK, PKC, and CDK4. PD166866 has clear antiproliferative effects.
-
In Vitro——
-
In Vivo——
-
SynonymsPD166866 | PD166866 | PD 166866
-
PathwayMembrane Transporter/Ion Channel
-
TargetOCT
-
RecptorFGFR1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number192705-79-6
-
Formula Weight396.45
-
Molecular FormulaC20H24N6O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : 10.33 mg/mL. 26.06 mM;
-
SMILESCOc1cc(OC)cc(c1)-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C
-
Chemical Name1-(2-amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)-3-(tert-butyl)urea.
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Panek RL, et al. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase. J Pharmacol Exp Ther. 1998 Jul;286(1):569-77.
molnova catalog



related products
-
OAC2
OAC2 is an Oct4-activating compound which activates expression through the Oct4 gene promoter.
-
CP-91149
CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 μM in the presence of glucose, 5- to 10-fold less potent in the absence of glucose.
-
PD-166866
PD166866 is a selective FGFR tyrosine kinase inhibitor.